Lilach Chen Zeltsburg

Title: Lilach Chen Zeltsburg: Innovator in Modified DNase Technology

Introduction

Lilach Chen Zeltsburg is a prominent inventor based in Nahariya, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of modified DNase proteins. With a total of 2 patents to her name, her work focuses on enhancing the efficacy of DNase I proteins for various medical applications.

Latest Patents

Zeltsburg's latest patents include innovative methods for modifying DNase I proteins. These modifications involve altering one or more amino acids of the DNase I protein non-cellularly. The resulting modified DNase I protein demonstrates improved DNA hydrolytic activity in the presence of actin, surpassing that of non-modified counterparts. These advancements have potential applications in reducing DNA content in sputum and treating conditions associated with excess extracellular DNA in bodily fluids, secretions, or tissues.

Career Highlights

Throughout her career, Lilach Chen Zeltsburg has worked with notable companies such as Protalix Ltd. and Biond Biologics Ltd. Her experience in these organizations has contributed to her expertise in biotechnological innovations and patent development.

Collaborations

Zeltsburg has collaborated with esteemed colleagues, including Ilya Ruderfer and Avidor Shulman. These partnerships have further enriched her research and development efforts in the field of modified DNase technology.

Conclusion

Lilach Chen Zeltsburg stands out as an influential inventor in the biotechnology sector, particularly with her advancements in modified DNase proteins. Her contributions have the potential to significantly impact medical treatments and improve patient outcomes.